Introduction
All you need to know about TRESIBA FlexTouch 200 Units/ml .
Welcome to Dwaey, specifically on TRESIBA FlexTouch 200 Units/ml page.
This medicine contains an important and useful components, as it consists of Insulin - Degludec.
TRESIBA FlexTouch 200 Units/ml is available in the market in concentration 200 Units/ml and in the form of Injection/Solution for.
NOVO NORDISK A/S is the producer of TRESIBA FlexTouch 200 Units/ml and it is imported from DENMARK, The most popular alternatives of TRESIBA FlexTouch 200 Units/ml are listed downward .
-
Active Substance
Insulin - Degludec
-
Size
3ml Pre-filled Pen x 3
-
Indications
- No indications available.
-
Type
Injection/Solution for
-
Company
NOVO NORDISK A/S
Frequently Asked Questions
TRESIBA FlexTouch 200 Units/ml should be stored according to the instructions provided by NOVO NORDISK A/S.
In general, it is recommended to store TRESIBA FlexTouch 200 Units/ml in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with TRESIBA FlexTouch 200 Units/ml may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking TRESIBA FlexTouch 200 Units/ml for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking TRESIBA FlexTouch 200 Units/ml. Some medications, including
TRESIBA FlexTouch 200 Units/ml, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of TRESIBA FlexTouch 200 Units/ml, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking TRESIBA FlexTouch 200 Units/ml without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking TRESIBA FlexTouch 200 Units/ml if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of TRESIBA FlexTouch 200 Units/ml during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 200 Units/ml,
and the specific recommendations of NOVO NORDISK A/S.
The effects of TRESIBA FlexTouch 200 Units/ml on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 200 Units/ml, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking TRESIBA FlexTouch 200 Units/ml with or without food may vary depending on the medication
and the recommendations of NOVO NORDISK A/S. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of TRESIBA FlexTouch 200 Units/ml in children or elderly individuals may depend on various factors, including
the specific medication, type Injection/Solution for, and the recommendations of NOVO NORDISK A/S. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of TRESIBA FlexTouch 200 Units/ml in children or elderly individuals.
0 Comments